Cancer is the second most common cause of death in the United States, trailing only heart
disease in incidence. Despite significant worldwide investment in research, cancer remains …

In 2004, the US Food and Drug Administration (FDA) released an important report entitled
“Innovation/Stagnation: Challenge and Opportunity on the Critical Path to New Medical …

Extracellular vesicles (EVs), as natural carriers of bioactive cargo, have a unique
micro/nanostructure, bioactive composition, and characteristic morphology, as well as …

Nucleic acids hold promise as biomolecules for future applications in biomedicine and
biotechnology. Their well-defined structures and compositions afford unique chemical …

DNA encodes the genetic information; recently, it has also become a key player in material
science. Given the specific Watson–Crick base‐pairing interactions between only four types …

Nano-drug delivery strategies have been highlighted in cancer treatment, and much effort
has been made in the optimization of bioavailability, biocompatibility, pharmacokinetics …

Cancer is a leading cause of death worldwide and accounts for several millions of deaths
every year.[1] The survival of cancer patients is strongly associated with the stage of the …

Simultaneous detection and imaging of multiple intracellular biomarkers hold great promise
for early cancer detection. Here, we introduce a four-color nanoprobe that can …

Gold nanoparticle accumulation in immune cells has commonly been viewed as a side effect
for cancer therapeutic delivery; however, this phenomenon can be utilized for developing …

Currently, functional single-stranded oligonucleotide probes, termed aptamers, generated
by an iterative technology, Systematic Evolution of Ligands by Exponential Enrichment …